Learn more

UPJOHN CO

Overview
  • Total Patents
    19,877
About

UPJOHN CO has a total of 19,877 patent applications. Its first patent ever was published in 1904. It filed its patents most often in United States, United Kingdom and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and machines are SEARLE & CO, SYNTEX INC and EISAI CO LTD.

Patent filings per year

Chart showing UPJOHN COs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sih John C 294
#2 Bundy Gordon L 248
#3 Hogg John A 245
#4 Magerlein Barney J 238
#5 Schneider William P 213
#6 Thaisrivongs Suvit 201
#7 Spero George B 199
#8 Kelly Robert C 191
#9 Morozowich Walter 190
#10 Babcock John C 190

Latest patents

Publication Filing date Title
US2009162883A1 Alzheimer's Disease Secretase, APP Substrates Thereof, and Uses Thereof
US2009075316A1 Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
AU2007205740A1 Methods of producing oxazolidinone compounds
AU2007203091A1 Substrates and assays for beta-secretase activity
AU2007200599A1 Selective norepinephrine reuptake inhibitors and methods of using the same
AU2006201473A1 Human ion channels
AU2005225037A1 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
AU2005220235A1 Selective norepinephrine reuptake inhibitors and methods of using the same
WO2005097096A1 A phenyl acetic acid cyclooxygenase-2 inhibitor for the treatment of ocular disorders
WO2005099691A1 Composition for treating elevated intraocular pressure
WO2005097110A1 Monotherapy for the modulation of intraocular pressure with cyclooxygenase-2 selective inhibitors
AU2005200492A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds
US7074927B2 Heterocyclic amines having central nervous system activity
US2005074808A1 G protein-coupled receptor expressed in brain
AU2004210549A1 G protein-coupled receptor expressed in brain
US2005049311A1 Medicinal products comprising prostaglandin compositions and methods of packaging such compositions
US2005059660A1 Novel combination
ZA200405335B Infection-resistant medical devices.
US2005287325A1 Pharmaceutical containers with low adsorption/absorption of active ingredients, and a method of testing materials for adsorption/absorption of active ingredients
US2005048122A1 Method for stabalizing timolol concentration